RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Study of the prevalence of Parkinson's disease using dopamine transporter imaging

Neurol Res 32(8):845-851 · 2010 · PMID 20021740

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

272편 검색→263편 판독→67편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Parkinson disease prevalence and dopamine transporter imaging Parkinson disease prevalence and dopamine transporter imaging

출판 연도

1990: 1편1199019951997: 1편12000: 1편120002004: 1편12005: 1편120052006: 1편12007: 2편22008: 1편12009: 2편22010: 2편220102012: 2편22013: 1편12014: 1편120152016: 2편22017: 4편42018: 12편122019: 4편42020: 5편520202021: 4편42022: 5편52023: 3편32024: 3편32025: 5편52026: 3편32026

선별된 67편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01emission · tomography18편

  1. 0.71

    Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study

    Piccini P, Morrish PK, Turjanski N et al. · Annals of neurology · 1997

  2. 0.68

    Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging

    Berendse HW, Ponsen MM · Parkinsonism & related disorders · 2009

  3. 0.68

    Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, and positron emission tomography findings

    Wang JL, Xiao B, Cui XX et al. · Movement disorders : official journal of the Movement Disorder Society · 2009

  4. 0.67

    Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?--a [99mTc]-TRODAT-1 SPECT study

    Shih MC, Franco de Andrade LA, Amaro EJ et al. · Movement disorders : official journal of the Movement Disorder Society · 2007

  5. 0.63

    What predicts cognitive decline in de novo Parkinson's disease?

    Arnaldi D, Campus C, Ferrara M et al. · Neurobiology of aging · 2012

  6. 0.62

    Evaluation of patients with Clinically Unclear Parkinsonian Syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1

    Felicio AC, Godeiro-Junior C, Shih MC et al. · Journal of the neurological sciences · 2010

  7. 0.62

    Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam

    Snow BJ, Peppard RF, Guttman M et al. · Archives of neurology · 1990

  8. 0.61

    Spatiotemporal patterns of putaminal dopamine processing in Parkinson's disease: A multi-tracer positron emission tomography study

    Fu JF, Wegener T, Klyuzhin IS et al. · NeuroImage. Clinical · 2022

  9. 0.57

    Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study

    Shyu WC, Lin SZ, Chiang MF et al. · Parkinsonism & related disorders · 2005

  10. 0.57

    Diagnostic value of micrographia in Parkinson's disease: a study with [(123)I]FP-CIT SPECT

    Eklund M, Nuuttila S, Joutsa J et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2022

  11. 0.57

    [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis

    Frings L, Henninger F, Treppner M et al. · Journal of Parkinson's disease · 2020

  12. 0.56

    Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease

    Brajkovic LD, Svetel MV, Kostic VS et al. · Hellenic journal of nuclear medicine · 2012

  13. 0.55

    Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease

    Gigante AF, Asabella AN, Iliceto G et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018

  14. 0.54

    Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease

    Varrone A, Pellecchia MT, Amboni M et al. · Neurology · 2004

  15. 0.53

    Predictive value of the smell identification test for nigrostriatal dopaminergic depletion in Korean tremor patients

    Hong JY, Chung SJ, Lee JE et al. · Parkinsonism & related disorders · 2013

  16. 0.53

    Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data

    Lee JW, Song YS, Kim H et al. · Medicine · 2021

  17. 0.51

    Motor asymmetry in Parkinson's disease: Diagnostic thresholds based on clinical scores and DaTSCAN imaging

    Voruz P, Peron J · Clinical parkinsonism & related disorders · 2025

  18. 0.50

    Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging

    Eckert T, Feigin A, Lewis DE et al. · Movement disorders : official journal of the Movement Disorder Society · 2007

02sleep behavior · disorder14편

  1. 0.76

    Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis

    Hattori M, Hiraga K, Satake Y et al. · NPJ Parkinson's disease · 2023

  2. 0.66

    Rhythm disturbances as a potential early marker of Parkinson's disease in idiopathic REM sleep behavior disorder

    Cochen De Cock V, de Verbizier D, Picot MC et al. · Annals of clinical and translational neurology · 2020

  3. 0.66

    Diabetes mellitus and Parkinson disease

    Pagano G, Polychronis S, Wilson H et al. · Neurology · 2018

  4. 0.60

    Differential striatal dopamine binding in Parkinson's Disease with and without REM sleep behavior disorder: A Tc-99 m TRODAT-1 SPECT study

    Wang PH, Chang YP, Chien CF et al. · GeroScience · 2025

  5. 0.60

    Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease

    Noyce AJ, Dickson J, Rees RN et al. · Movement disorders : official journal of the Movement Disorder Society · 2018

  6. 0.59

    Speech difficulties in early de novo patients with Parkinson's disease

    Polychronis S, Niccolini F, Pagano G et al. · Parkinsonism & related disorders · 2019

  7. 0.58

    Discriminating between proposed Brain-First and Body-First Parkinson's disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis

    Palermo G, Aghakhanyan G, Bellini G et al. · NPJ Parkinson's disease · 2025

  8. 0.58

    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

    Pagano G, De Micco R, Yousaf T et al. · Neurology · 2018

  9. 0.57

    Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder

    Dusek P, Ibarburu VLYL, Bezdicek O et al. · Scientific reports · 2019

  10. 0.57

    Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease

    Sun Y, Choi Y, Park CW et al. · Movement disorders : official journal of the Movement Disorder Society · 2026

  11. 0.53

    Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT

    Unger MM, Moller JC, Stiasny-Kolster K et al. · Movement disorders : official journal of the Movement Disorder Society · 2008

  12. 0.53

    Constipation is not associated with dopamine transporter pathology in early drug-naive patients with Parkinson's disease

    Pagano G, Yousaf T, Wilson H et al. · European journal of neurology · 2018

  13. 0.52

    Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [(123) I]-metaiodobenzylguanidine cardiac scintigraphy

    Fujishiro H, Okuda M, Iwamoto K et al. · Psychiatry and clinical neurosciences · 2018

  14. 0.51

    Longitudinal associations between cerebrospinal fluid glial activation markers, depression, and dopamine transporter availability in patients with Parkinson's disease

    Yang D, Chen F, Ren J et al. · Journal of neurology · 2024

03white matter · regression12편

  1. 0.83

    Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults

    Chahine L, Rosso AL, Troidl I et al. · Neurology · 2025

  2. 0.68

    Neural correlates of self-awareness of cognitive deficits in non-demented patients with Parkinson's disease

    Yoo HS, Kwon H, Chung SJ et al. · European journal of neurology · 2021

  3. 0.62

    Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease

    Jeong SH, Chung SJ, Yoo HS et al. · Brain : a journal of neurology · 2021

  4. 0.61

    Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

    Caspell-Garcia C, Simuni T, Tosun-Turgut D et al. · PloS one · 2017

  5. 0.58

    Dynamic Changes in Midbrain-Striatal Association and Their Relationship With Levodopa-Induced Dyskinesia in Parkinson's Disease

    Jeong EH, Lee JY, Park HS et al. · Parkinson's disease · 2026

  6. 0.55

    Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease

    Roos DS, Twisk JWR, Raijmakers PGHM et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2019

  7. 0.55

    Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease

    Liu R, Umbach DM, Troster AI et al. · Parkinsonism & related disorders · 2020

  8. 0.55

    Drooling in Parkinson's disease: A potential clinical marker of disease severity

    Igami E, Nishikawa N, Iwaki H et al. · Parkinsonism & related disorders · 2025

  9. 0.54

    Influence of Striatal Dopamine, Cerebral Small Vessel Disease, and Other Risk Factors on Age-Related Parkinsonian Motor Signs

    Rosano C, Metti AL, Rosso AL et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020

  10. 0.54

    Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease

    Sampedro F, Marin-Lahoz J, Martinez-Horta S et al. · Neurobiology of disease · 2019

  11. 0.51

    White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease

    Jeong SH, Lee HS, Jung JH et al. · Movement disorders : official journal of the Movement Disorder Society · 2021

  12. 0.50

    Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson's disease

    Costello H, Schrag AE, Howard R et al. · medRxiv : the preprint server for health sciences · 2023

04response · tremor9편

  1. 0.93

    Study of the prevalence of Parkinson's disease using dopamine transporter imaging 이 논문

    Kim JM, Kim JS, Kim KW et al. · Neurological research · 2010

  2. 0.67

    Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study

    Pasquini J, Ceravolo R, Qamhawi Z et al. · Brain : a journal of neurology · 2018

  3. 0.64

    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2

    Boot E, Butcher NJ, Udow S et al. · Neurology · 2018

  4. 0.63

    Genetic and clinical study of PARK7 in Japanese Parkinson's disease

    Ishiguro M, Funayama M, Hatano T et al. · Heliyon · 2024

  5. 0.62

    Parkinson's Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees

    Gago MF, Azevedo O, Guimaraes A et al. · Journal of Parkinson's disease · 2020

  6. 0.55

    Parkinson's disease in GTP cyclohydrolase 1 mutation carriers

    Mencacci NE, Isaias IU, Reich MM et al. · Brain : a journal of neurology · 2014

  7. 0.54

    GCH1 mutations in dopa-responsive dystonia and Parkinson's disease

    Yoshino H, Nishioka K, Li Y et al. · Journal of neurology · 2018

  8. 0.54

    GBA1 variants and dopaminergic imaging in essential tremor with atypical features: A comparative study with Parkinson's disease

    Suoranta M, Kytovuori L, Haataja E et al. · Parkinsonism & related disorders · 2026

  9. 0.54

    Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease

    Butcher NJ, Marras C, Pondal M et al. · Brain : a journal of neurology · 2017

05idiopathic · progressive supranuclear7편

  1. 0.79

    High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease

    Sasaki S · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

  2. 0.66

    Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study

    Nicastro N, Burkhard PR, Garibotto V · Journal of the neurological sciences · 2018

  3. 0.62

    Epidemiology of Parkinson's disease and akinetic syndromes

    Tanner CM, Aston DA · Current opinion in neurology · 2000

  4. 0.62

    Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging

    Marshall VL, Patterson J, Hadley DM et al. · Nuclear medicine communications · 2006

  5. 0.61

    Scan without evidence of dopaminergic deficit: A 10-year retrospective study

    Nicastro N, Garibotto V, Badoud S et al. · Parkinsonism & related disorders · 2016

  6. 0.58

    Differential involvement of nigral subregions in idiopathic parkinson's disease

    Sung YH, Lee J, Nam Y et al. · Human brain mapping · 2018

  7. 0.55

    PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study

    Backstrom D, Domellof ME, Granasen G et al. · Journal of the neurological sciences · 2017

06functional · connectivity5편

  1. 0.71

    Automated video-based assessment of facial bradykinesia in de-novo Parkinson's disease

    Novotny M, Tykalova T, Ruzickova H et al. · NPJ digital medicine · 2022

  2. 0.64

    Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging

    Rusz J, Tykalova T, Novotny M et al. · European journal of neurology · 2022

  3. 0.58

    Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients

    Boccalini C, Nicastro N, Perani D et al. · NeuroImage. Clinical · 2024

  4. 0.52

    Dopamine Transporter Imaging has no Impact on Functional Outcomes in de Novo Probable Parkinson's Disease

    Hickey PT, Kuchibhatla M, Scott B et al. · Journal of Parkinson's disease · 2017

  5. 0.51

    Real-World Testing of a Machine Learning-Derived Visual Scale for Tc99m TRODAT-1 for Diagnosing Lewy Body Disease: Comparison with a Traditional Approach Using Semiquantification

    Chiu PY, Hou PN, Hung GU et al. · Journal of personalized medicine · 2022

07disorders · syndrome2편

  1. 0.63

    Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease

    Smith KM, Xie SX, Weintraub D · Journal of neurology, neurosurgery, and psychiatry · 2016

  2. 0.59

    Predictors of dopamine dysregulation syndrome in patients with early Parkinson's disease

    Liang K, Li X, Ma J et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023